Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China.
about
High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatmentAntibiotic treatment for Helicobacter pylori: Is the end coming?Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature reviewSecond and third line treatment options for Helicobacter pylori eradicationA review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.The clinical and bacteriological factors for optimal levofloxacin-containing triple therapy in second-line Helicobacter pylori eradicationNovel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.Centralized isolation of Helicobacter pylori from multiple centers and transport condition influences.Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study.Progressive genomic convergence of two Helicobacter pylori strains during mixed infection of a patient with chronic gastritisAnti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivoThe Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study.Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Extremely High Prevalence of Metronidazole-Resistant Helicobacter pylori Strains in Mountain People (Karen and Hmong) in Thailand.Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance.The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China.Multiple Genetic Analysis System-Based Antibiotic Susceptibility Testing in Helicobacter pylori and High Eradication Rate With Phenotypic Resistance-Guided Quadruple TherapyHow antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Molecular and Proteomic Analysis of Levofloxacin and Metronidazole Resistant Helicobacter pylori.Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies.Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea.Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, PeruTreatment of Helicobacter pylori infection 2013.Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.Treatment of Helicobacter pylori infection 2014.Quinolone-containing therapies in the eradication of Helicobacter pyloriCurrent and potential applications of bismuth-based drugs.Review: efficacy and safety of hybrid therapy for Helicobacter pylori infection: a systematic review and meta-analysis.Review: clinical management of Helicobacter pylori infection in China.Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran.Critical Role of Antimicrobial Peptide Cathelicidin for Controlling Helicobacter pylori Survival and Infection.Randomized Clinical Trial: Esomeprazole, Bismuth, Levofloxacin, and Amoxicillin or Cefuroxime as First-Line Eradication Regimens for Helicobacter pylori Infection.Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial.Hybrid Therapy as First-Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates.Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization.Resistance of Helicobacter pylori to furazolidone and levofloxacin: A viewpoint.Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study.Evaluation of first-line bismuth-containing 7-day concomitant quintuple therapy for Helicobacter pylori eradication.
P2860
Q26771197-789E173D-8367-4949-8446-5706241952D0Q26777623-D24E7867-25C9-4407-975A-7B68C8A18AE7Q26785651-69E5FEAB-6BD9-49B0-A99C-369F2D1DC258Q26829666-1F52E19E-A0B8-4618-9AC2-85D8CDC44466Q27687842-8D4F5EC5-E5DA-4118-99D5-30043F1B8EA0Q28542458-4A8938C2-2475-40DE-9C1E-F8E2DF7E7776Q33639114-AB69E8F8-7A36-423F-AFA4-E665AC54B626Q34986052-3556D3AC-FAA6-44D6-836C-19F3C4AE1E07Q35015521-EAA37739-FFBE-4DCE-8EEA-4FA23DCBDC0DQ35152391-CC50F7E3-19AC-4E64-BC63-93100131A834Q35351292-A4788596-F831-4C89-BBD8-1B724F2155A6Q35375400-CFBF3C31-5F3D-4482-9C94-965DD75C39C3Q35571249-66DF9FDD-9477-4299-B536-FA2A43154623Q35598058-B8999191-49C1-4C05-846E-2B11F63487F4Q35924722-14DE647D-B15D-4A49-A77D-BEB55F7D494CQ36360817-C3DFAC42-DF65-43AF-868D-82495230783DQ36653595-3954674C-4367-43C2-8A79-9EA4E0C334FFQ37328573-28F24FA7-6BFC-4EB9-A396-AE85F65CD2D7Q37378899-BB64650C-A067-4408-A7D8-3F3433198A18Q37505662-1227F64D-158C-46CF-A8F6-8C1BB0077F3AQ37533456-FEA775A1-274B-4FC1-87C4-803A29E23121Q37587260-99314138-F318-40A6-8945-DA5DCC3B129AQ37656247-9DEFBBD6-7C31-48E8-87CA-39F811AE4BD6Q37705632-51FB2A70-DB35-4B3E-8A46-1670D4750C0AQ38134877-EFDD702C-7FC9-48D3-9A5E-6A880C2A93B9Q38238746-50B9E748-687B-4943-805B-7745C060CF7AQ38244257-42989D7F-B7F1-44DE-8034-EB4C325B7CCDQ38253054-8B4D389A-B379-4431-83D9-C6B22F53A3CEQ38253836-2F06679B-1727-42CD-B3C1-1D2252C82A1CQ38266303-9C4C7986-8B8F-44AA-831F-508163C9DFB5Q38266432-C92B3E09-E1FB-447C-A8F3-FD916A913F08Q38747268-362ED371-44B6-4138-BEBD-066A9A81D8A3Q38800391-B7293B43-097B-4008-B8AA-0A67BD393252Q38846038-094F91A6-71DD-40AD-8A5F-4DAE77401671Q40702356-67A26127-4F13-452D-914E-7C5ED75D3B89Q40818792-5BAAF704-F6C0-462A-ACA1-A42C63A3F3F4Q42695275-FC8AADAB-21FE-4BE0-808B-BFB6ACCE99ACQ43265426-3B2FAA3A-DC91-41CD-AE76-23D9C75C619AQ43854108-10CAAE29-AE41-4309-B787-830C66D152F4Q47222389-A04D25E4-0CCA-4671-A281-D74B908B1A3A
P2860
Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Antibiotic resistance of Helic ...... heast Coastal Region of China.
@en
Antibiotic resistance of Helic ...... heast Coastal Region of China.
@nl
type
label
Antibiotic resistance of Helic ...... heast Coastal Region of China.
@en
Antibiotic resistance of Helic ...... heast Coastal Region of China.
@nl
prefLabel
Antibiotic resistance of Helic ...... heast Coastal Region of China.
@en
Antibiotic resistance of Helic ...... heast Coastal Region of China.
@nl
P2093
P2860
P921
P356
P1433
P1476
Antibiotic resistance of Helic ...... heast Coastal Region of China.
@en
P2093
Fengzhe Jin
Hongzhang Li
Jiakun Zhang
Jianzhong Zhang
Junliang Mao
Mizu Jiang
P2860
P304
P356
10.1111/HEL.12046
P577
2013-02-19T00:00:00Z